Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin H Lachmann

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2012
Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature reviewIgnacio Rubio-Agusti, Maja Kojovic, Mark J Edwards, et al.
Journal of Proteome Research|March 8, 2013
The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patientsVictoria Manwaring, Wendy E Heywood, Robert Clayton, et al.
Journal of Inherited Metabolic Disease|January 7, 2018
Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 monthsMelissa P Wasserstein, George A Diaz, Robin H Lachmann, et al.
Orphanet Journal of Rare Diseases|February 1, 2022
Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational studyPhilip J Hennis, Elaine Murphy, Rick I Meijer, et al.
JIMD Reports|March 13, 2015
Bladder and Bowel Dysfunction Is Common in Both Men and Women with Mutation of the ABCD1 Gene for X-Linked AdrenoleukodystrophyJohann Hofereiter, Matthew D Smith, Jai Seth, et al.
Molecular Genetics and Metabolism|July 5, 2020
Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatmentBeth L Thurberg, George A Diaz, Robin H Lachmann, et al.
The American Journal of Cardiology|October 9, 2012
Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry diseaseCaroline J Coats, Valentina Parisi, Monica Ramos, et al.
Neuromuscular Disorders : NMD|February 10, 2018
GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2)Mahalekshmi Desikan, Renata Siciliani Scalco, Andreea Manole, et al.
Journal of Inherited Metabolic Disease|February 21, 2018
Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutationsDouglas Chesher, Michael Oddy, Ulpee Darbar, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 24, 2015
Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state (1)H NMR studiesFay Probert, Victor Ruiz-Rodado, Xiaoyu Zhang, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2012
Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature reviewIgnacio Rubio-Agusti, Maja Kojovic, Mark J Edwards, et al.
Journal of Proteome Research|March 8, 2013
The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patientsVictoria Manwaring, Wendy E Heywood, Robert Clayton, et al.
Journal of Inherited Metabolic Disease|January 7, 2018
Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 monthsMelissa P Wasserstein, George A Diaz, Robin H Lachmann, et al.
Orphanet Journal of Rare Diseases|February 1, 2022
Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational studyPhilip J Hennis, Elaine Murphy, Rick I Meijer, et al.
JIMD Reports|March 13, 2015
Bladder and Bowel Dysfunction Is Common in Both Men and Women with Mutation of the ABCD1 Gene for X-Linked AdrenoleukodystrophyJohann Hofereiter, Matthew D Smith, Jai Seth, et al.
Molecular Genetics and Metabolism|July 5, 2020
Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatmentBeth L Thurberg, George A Diaz, Robin H Lachmann, et al.
The American Journal of Cardiology|October 9, 2012
Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry diseaseCaroline J Coats, Valentina Parisi, Monica Ramos, et al.
Neuromuscular Disorders : NMD|February 10, 2018
GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2)Mahalekshmi Desikan, Renata Siciliani Scalco, Andreea Manole, et al.
Journal of Inherited Metabolic Disease|February 21, 2018
Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutationsDouglas Chesher, Michael Oddy, Ulpee Darbar, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 24, 2015
Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state (1)H NMR studiesFay Probert, Victor Ruiz-Rodado, Xiaoyu Zhang, et al.
Pageof 6